Novel Translational Pharmacology Approaches On Dose Reduction And Alternative Scheduling For The Combination Of Jak Inhibitor, Ruxolitinib, Pim Inhibitor, Lgh447, And Cdk4/6 Inhibitor, Lee011 In A Preclinical Model Of Myeloproliferative Neoplasia
CANCER RESEARCH(2015)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要